Statistics for Anebulo Pharmaceuticals, (id:5709 ANEB)

Valuation metrics

Market cap

37.86M

Enterprise value

36.32M

Trailing P/E (ttm)

-4.56

Forward P/E

-2.25

PEG ratio

-2.25

Price/Sales (ttm)

Price/Book (mrq)

9.93

Enterprise Value/Revenue

Enterprise Value/EBITDA

-4.51

Overview

Shares outstanding

25.93M

Float

3.91M

Shares short

10.76K

% Held by insiders

0.64%

% Held by institutions

0.28%

Average volume (10 days)

4.25K

Average volume (90 days)

Price summary

52-Week low

1.25

52-Week high

3.30

52-Week change

-53.42%

Beta

-1.01

50-Day moving average

1.88

200-Day moving average

2.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

June 30th, 2024

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-65.97%

Return on equity

-113.80%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-8,201,703.00

Diluted EPS (ttm)

-0.30

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

3.09M

Total cash per share (mrq)

0.12

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

1.35K%

Book value per share (mrq)

0.15

Cash flow

Cash flow statement

-8,090,849.00

Levered free cash flow (LFCF)

-5,176,637.00